Item 2.02. Results of Operations and Financial Condition.

In connection with the press release described in Item 8.01 below, on January 7, 2021, Eiger BioPharmaceuticals, Inc. (the "Company") provided, on a preliminary and unaudited basis, certain estimates regarding its cash, cash equivalents and investments as of December 31, 2020 on a pro forma basis. The estimate is a preliminary estimate based on currently available information and does not present all necessary information for a complete understanding of the Company's financial condition as of December 31, 2020 or the Company's results of operations for the year ended December 31, 2020.

Item 8.01. Other Events.

On January 7, 2021, the Company issued a press release titled "Eiger Updates on 2020 Progress and 2021 Plans." A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Forward-Looking Statements

Statements in this report that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to the pro forma cash, cash equivalents and investments as of December 31, 2020. Such forward-looking statements involve known and unknown risks, uncertainties and other factors. More information about the risks the Company faces is included under the headings "Risk Factors" in the Company's most recently filed documents with the U.S. Securities and Exchange Commission. The Company is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this report as a result of new information, future events or otherwise.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
  No.       Description

99.1          Press release, dated January 7, 2021, titled "Eiger Updates on 2020
            Progress and 2021 Plans."

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses